February 2015 Tucson pulmonary journal club: fibrinolysis for PE
No abstract available. Article truncated at 150 words. The role of fibrinolytic therapy among patients with intermediate-risk pulmonary embo-lism (PE) is controversial (1). When right ventricular dysfunction and myocardial injury are associated with PE, there is an increased risk of adverse events (...
Main Authors: | Ganesh A, Bime C, Gerald J |
---|---|
Format: | Article |
Language: | English |
Published: |
Arizona Thoracic Society
2015-02-01
|
Series: | Southwest Journal of Pulmonary and Critical Care |
Subjects: | |
Online Access: | http://www.swjpcc.com/pulmonary-journal-club/2015/2/26/february-2015-tucson-pulmonary-journal-club-fibrinolysis-for.html |
Similar Items
-
Plasminogen activators in acute management of thrombosis
by: E. O. Taratukhin
Published: (2013-06-01) -
COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE
by: E. S. Mazur, et al.
Published: (2017-09-01) -
Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis
by: Holger Seidel, et al.
Published: (2021-08-01) -
Fibrinolysis and bleeding of unknown cause
by: Dino Mehic, et al.
Published: (2021-05-01) -
Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
by: Marco Ranucci, et al.
Published: (2020-10-01)